Form D · Biotechnology
Ainos, Inc.
San Diego, CA · CIK 0001014763
Offering snapshot reported May 3, 2021 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 3, 2021 | Initial | $20,000,000 | No comparison | 0 | SEC filing |
| Aug 29, 2018 | Amendment | $721,033 | $245,548vs Aug 7, 2018 | 10 | SEC filing |
| Aug 7, 2018 | Amendment | $475,485 | -$105,548vs Dec 19, 2017 | 6 | SEC filing |
| Dec 19, 2017 | Initial | $581,033 | No comparison | 0 | SEC filing |
| Oct 31, 2017 | Amendment | $476,479 | $54,604vs Oct 24, 2016 | 4 | SEC filing |
| Oct 24, 2016 | Amendment | $421,875 | $365,625vs May 6, 2016 | 4 | SEC filing |
| May 6, 2016 | Initial | $56,250 | No comparison | 2 | SEC filing |
| Apr 7, 2016 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Aug 3, 2015 | Initial | $37,500 | No comparison | 1 | SEC filing |
| May 31, 2011 | Initial | $40,000 | No comparison | 1 | SEC filing |
| May 5, 2011 | Initial | $63,000 | No comparison | 1 | SEC filing |
| May 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-398003
Source: Form D, filed May 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Chen | Director, Executive |
| Yasushi Chikagami | Director |
| Bernard Cohen | Executive |
| Joseph M Cummins | Director, Executive |
| Martin J Cummins | Executive |
| Thomas D'alonzo | Director |
| Daniel Fisher | Director |
| Dennis Moore | Director |
| Nicholas Moren | Director |
| Edward L Morris | Director |
| James A Page | Director |
| Paul Tibbits | Director |
| Marian Tibbits | Director |
| Chun Hsien Tsai | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8880 Rio San Diego Drive Suite 800
San Diego, CA, 92108
San Diego, CA, 92108